Concurrent Doxorubicin Plus Docetaxel Is Not More Effective Than Concurrent Doxorubicin Plus Cyclophosphamide in Operable Breast Cancer With 0 to 3 Positive Axillary Nodes: North American Breast Cancer Intergroup Trial E 2197

PURPOSE: The combination of doxorubicin and cyclophosphamide (AC) is a standard adjuvant regimen. Doxorubicin and docetaxel (AT) is one of the most active cytotoxic regimens for metastatic breast cancer. The purpose of this trial was to determine whether adjuvant AT improved disease-free survival co...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Goldstein, Lori J., O'Neill, Anne, Sparano, Joseph A., Perez, Edith A., Shulman, Lawrence N., Martino, Silvana, Davidson, Nancy E.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2008
Fag:
Breast Cancer
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654376/
https://ncbi.nlm.nih.gov/pubmed/18678836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.16.7841
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker